ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

April 26, 2002

Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended

February 24, 2012

BMS Award Honors Jordan; Matthews Media Wins $23 Million Contract From MCI.

April 6, 2001

Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program

July 23, 1999

In NEJM Letter, Henschke Acknowledges Error In 2006 I-ELCAP Paper; Critics Call For Audit.

August 8, 2008

NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.

February 23, 2001